Analysis of the Transcriptional Activity of Immune Response Genes in the Blood of Patients with Acute Urticaria
DOI:
https://doi.org/10.3889/oamjms.2022.8781Keywords:
Acute urticaria, mRNA, Innate and adaptive immune responsesAbstract
OBJECTIVE: Alterations in the transcriptional activity of some immunoregulatory genes can play a key in the pathogenesis of acute urticarial (AU). Minimally-invasive markers of the transcriptional activity of immune response genes are essential not only for predicting the severity and activity of the disease but also as a potential target for therapy.
METHODS: In our research, we applied a pathway-specific polymerase chain reaction PCR array (Human Innate and Adaptive Immune Responses RT2 Profiler PCR Array, QIAGEN, Germany) to detect and verify innate and adaptive immune responses pathway-focused genes expression in patients suffering from AU and control group.
RESULTS: The AU development was accompanied by an increase in the transcriptional activity of genes for a number of costimulation molecules such as CD40, CD40LG, CD80 (B7-1), and C-reactive protein and myeloperoxidase genes either. Under AU conditions, transcriptional induction of genes of several cytokines was also observed: Interferon gamma, interleukin (IL4), IL5, IL17A, tumor necrosis factor, and also chemokine CXCL8. This process was also accompanied by an increase in the transcriptional activity of the RAR-related orphan receptor C Th17 differentiation regulator, the NLRP3 inflammasome genes, and the NFKB1 transcription factor. Such changes occurred against the background of transcriptional repression of the FOXP3 gene and the Treg-dependent suppressor cytokine IL10. The expression of other studied genes did not differ significantly from the controls.
CONCLUSIONS: The development of acute urticaria led to the transcriptional activation of pro-inflammatory signaling against the background of a deficiency of the suppressor link. Detected changes in gene expression can be important for targeted therapy.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Pier J, Bingemann TA. Urticaria, angioedema, and anaphylaxis. Pediatr Rev. 2020;41:283-92. http://doi.org/10.1542/pir.2019-0056 DOI: https://doi.org/10.1542/pir.2019-0056
Radonjic-Hoesli S, Hofmeier KS, Micaletto S, Schmid- Grendelmeier P, Bircher A, Simon D. Urticaria and angioede-ma: An update on classification and pathogenesis. Clin Rev Allergy Immunol. 2018;54(1):88-101. https://doi.org/10.1007/s12016-017-8628-1 PMid:28748365 DOI: https://doi.org/10.1007/s12016-017-8628-1
Folci M, Ramponi G, Brunetta EA. Comprehensive approach to urticaria: From clinical presentation to modern bio-logical treatments through pathogenesis. Adv Exp Med Biol. 2021;1326:111-37. https://doi.org/10.1007/5584_2020_612 PMid:33385176 DOI: https://doi.org/10.1007/5584_2020_612
Marques-Mejías MA, Tomás-Pérez M, Vilà-Nadal G, Quirce S. Acute urticaria in the pediatric emergency department: Management and possible triggers. Ann Allergy Asthma Immunol. 2020;124:396-97. https://doi.org/10.1016/j.anai.2020.01.007 PMid:31981615 DOI: https://doi.org/10.1016/j.anai.2020.01.007
Bilous I, Pavlovych L, Krynytska I, Marushchak M, Kamyshnyi A. Apoptosis and cell cycle pathway-focused genes expression analysis in patients with different forms of thyroid pathology. Open Access Maced J Med Sci. 2020;8:784-92. https://doi.org/10.3889/oamjms.2020.4760 DOI: https://doi.org/10.3889/oamjms.2020.4760
Bilous II, Korda MM, Krynytska IY, Kamyshnyi AM. Nerve impulse transmission pathway-focused genes expression analysis in patients with primary hypothyroidism and autoimmune thyroiditis. Endocr Regul. 2020;54:109-18. https://doi.org/10.2478/enr-2020-0013 PMid:32597152 DOI: https://doi.org/10.2478/enr-2020-0013
Bilous II, Pavlovych LB, Kamyshnyi AM. Primary hypothyroidism and autoimmune thyroiditis alter the transcription-al activity of genes regulating neurogenesis in the blood of patients. Endocr Regul. 2021;55:5-15. https://doi.org/10.2478/enr-2021-0002 PMid:33600668 DOI: https://doi.org/10.2478/enr-2021-0002
Kamyshna II, Pavlovych LB, Maslyanko VA, Kamyshnyi AM. Analysis of the transcriptional activity of genes of neu-ropeptides and their receptors in the blood of patients with thyroid pathology. J Med Life. 2021;14:243-9. https://doi.org/10.25122/jml-2020-0183 PMid:34104248 DOI: https://doi.org/10.25122/jml-2020-0183
Kamyshna I, Kamyshnyi A. Transcriptional activity of neurotrophins genes and their receptors in the peripheral blood in patients with thyroid diseases in bukovinian population of Ukraine. Open Access Maced J Med Sci. 2021;9:208-16. https://doi.org/10.3889/oamjms.2021.6037 DOI: https://doi.org/10.3889/oamjms.2021.6037
Putilin DA, Evchenko SY, Fedoniuk LY, Tokarskyy OS, Kamyshny OM, Migenko LM, et al. The influence of metformin to the transcriptional activity of the mTOR and FOX3 genes in parapancreatic adipose tissue of streptozotocin-induced diabetic rats. J Med Life. 2020;13(1):50-5. https://doi.org/10.25122/ jml-2020-0029 PMid:32341701
Nosulenko IS, Voskoboynik OY, Berest GG, Safronyuk SL, Kovalenko SI, Kamyshnyi OM, et al. Synthesis and antimicrobial activity of 6-thioxo-6, 7-dihydro-2H-[1, 2, 4]triazino[2, 3-c]-quinazolin-2-one derivatives. Sci Pharm. 2014;82(3):483-500. https://doi.org/10.3797/scipharm.1402-10 PMid:25853063 DOI: https://doi.org/10.3797/scipharm.1402-10
Topol IA, Kamyshny AM, Abramov AV, Kolesnik YM. Expression of XBP1 in lymphocytes of the small intestine in rats under chronic social stress and modulation of intestinal microflora composition. Fiziol Zh. 2014;60(2):38-44. PMid:25007519 DOI: https://doi.org/10.15407/fz60.02.038
Kamyshna I, Pavlovych L, Malyk I, Kamyshnyi A. 25-OH Vitamin D blood serum linkage with VDR gene polymorphism (rs2228570) in thyroid pathology patients in the West-Ukrainian population. J Med Life. 2021;14(4):549-56. https://doi.org/10.25122/jml-2021-0101 PMid:34621381 DOI: https://doi.org/10.25122/jml-2021-0101
Kamyshna II, Pavlovych LB, Sydorchuk LP, Malyk IV, Kamyshnyi AM. BDNF blood serum linkage with BDNF gene polymorphism (rs6265) in thyroid pathology patients in the West-Ukrainian population. Endocr Regul. 2021;55(4):193-203. https://doi.org/10.2478/enr-2021-0021 PMid:34879183 DOI: https://doi.org/10.2478/enr-2021-0021
Lin CE, Kaptein JS, Sheikh J. Differential expression of microRNAs and their possible roles in patients with chronic idiopathic urticaria and active hives. Allergy Rhinol. 2017;8:67-80. https://doi.org/10.2500/ar.2017.8.0199 PMid:28583230 DOI: https://doi.org/10.2500/ar.2017.8.0199
Li J, Guo A, Chen W, Bin L, He Y, Zhu W, et al. Association of ORAI1 gene polymorphisms with chronic spontaneous urticaria and the efficacy of the nonsedating H1 antihistamine desloratadine. J Allergy Clin Immunol. 2017;139:1386-e9. https://doi.org/10.1016/j.jaci.2016.10.017 PMid:27864023 DOI: https://doi.org/10.1016/j.jaci.2016.10.017
Metz M, Torene R, Kaiser S, Beste MT, Staubach P, Bauer A, et al. Omalizumab normalizes the gene expression signature of lesional skin in patients with chronic spontaneous urticaria: A randomized, double-blind, placebo-controlled study. Allergy. 2019;74:141-51. https://doi.org/10.1111/all.13547 PMid:29974963 DOI: https://doi.org/10.1111/all.13547
Giménez-Arnau A, Curto-Barredo L, Nonell L, Puigdecanet E, Yelamos J, Gimeno R, et al. Transcriptome analysis of severely active chronic spontaneous urticaria shows an overall immunological skin involvement. Allergy. 2017;72:1778-90. https://doi.org/10.1111/all.13183 PMid:28407332 DOI: https://doi.org/10.1111/all.13183
Zhang Y, Zhang H, Du S, Yan S, Zeng J. Advanced biomarkers: Therapeutic and diagnostic targets in urticaria. Int Arch Allergy Immunol. 2021;29:1-15. https://doi.org/10.1159/000515753 PMid:33915552 DOI: https://doi.org/10.1159/000515753
Sarkar TK, Sil A, Pal S, Ghosh C, Das NK. Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: A double-blind, random-ized, controlled trial. Indian J Dermatol Venereol Leprol. 2017;83:561-8. https://doi.org/10.4103/ijdvl.IJDVL_551_16 PMid:28656910 DOI: https://doi.org/10.4103/ijdvl.IJDVL_551_16
Wang X, Liu J, Song S, Xu B, Tan X, Si S. Detection and analysis of toll-like receptors and DC-SIGN expression in peripheral blood mononuclear cells from patients with chronic urticaria. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014;30:736-9. PMid:25001940
Giménez-Arnau AM, DeMontojoye L, Asero R, Cugno M, Kulthanan K, Yanase Y, et al. The patho-genesis of chronic spontaneous urticaria: The role of infiltrating cells. J Allergy Clin Immunol Pract. 2021;9:2195-208. https://doi.org/10.1016/j.jaip.2021.03.033 DOI: https://doi.org/10.1016/j.jaip.2021.03.033
Deza G, Ricketti PA, Gimenez-Arnau AM, Casale TB. Emerging biomarkers and therapeutic pipelines for chronic spontaneous urticaria. J Allergy Clin Immunol Pract. 2018;6:1108-17. https://doi.org/10.1016/j.jaip.2018.02.024 PMid:30033912 DOI: https://doi.org/10.1016/j.jaip.2018.02.024
Toubi E, Vadasz Z. The emerging role of IL-17 in the immune-pathogenesis of chronic spontaneous urticaria. Immunotargets Ther. 2020;9:217-23. https://doi.org/10.2147/ITT.S266410 PMid:33134229 DOI: https://doi.org/10.2147/ITT.S266410
Sabag DA, Matanes L, Bejar J, Sheffer H, Barzilai A, Church MK, et al. Interleukin-17 is a potential player and treatment target in severe chronic spontaneous urticaria. Clin Exp Allergy. 2020;50:799-804. https://doi.org/10.1111/cea.13616 PMid:32412136 DOI: https://doi.org/10.1111/cea.13616
Grzanka A, Damasiewicz-Bodzek A, Kasperska-Zajac A. The relationship between circulating concentrations of interleu-kin 17 and C reactive protein in chronic spontaneous urticaria. Allergy Asthma Clin Immunol. 2017;10:25-31. https://doi.org/10.1186/s13223-017-0197-6 PMid:28491102 DOI: https://doi.org/10.1186/s13223-017-0197-6
Maurer M, Khan DA, Komi DE, Kaplan AP. Biologics for the use in chronic spontaneous urticaria: When and which. J Allergy Clin Immunol Pract. 2021;9:1067-78. https://doi.org/10.1016/j.jaip.2020.11.043 PMid:33685605 DOI: https://doi.org/10.1016/j.jaip.2020.11.043
Atwa MA, Emara AS, Youssef N, Bayoumy NM. Serum concentration of IL-17, IL-23 and TNF-a among patients with chronic spontaneous urticaria: Association with disease activity and autologous serum skin test. J Eur Acad Dermatol Venereol. 2014;28:469-74. https://doi.org/10.1111/jdv.12124 PMid:23451767 DOI: https://doi.org/10.1111/jdv.12124
Bangsgaard N, Skov L, Zachariae C. Treatment of refractory chronic spontaneous urticaria with adalimumab. Acta Derm Venereol. 2017;97(4):524-5. https://doi.org/10.2340/00015555-2573 PMid:27840884 DOI: https://doi.org/10.2340/00015555-2573
Alasandagutti ML, Ponnana M, Sivangala R, Thada S, Joshi L, Hussain H, et al. Role of IFN-gamma and IL-6 cytokines and their association in determining susceptibility to chronic idiopathic urticaria. Genet Test Mol Biomarkers. 2014;18(12):804-9. https://doi.org/10.1089/gtmb.2014.0193 PMid:25409241 DOI: https://doi.org/10.1089/gtmb.2014.0193
Grieco T, Porzia A, Paolino G, Chello C, Sernicola A, Faina V, et al. IFN-γ/IL-6 and related cytokines in chronic spontaneous urticaria: Evaluation of their pathogenetic role and changes during omali-zumab therapy. Int J Dermatol. 2020;59:590-4. https://doi.org/10.1111/ijd.14812 PMid:32048727 DOI: https://doi.org/10.1111/ijd.14812
Degirmenci PB, Kirmaz C, Vatansever S, Onur E, Nal E, Erdin S, Ozyurt B. Analysis of the association of chronic spontaneous urticaria with interlekin-4, -10, transforming growth factor-beta1, interferongamma, interleukin-17A and -23 by autologous serum skin test. Postepy Dermatol Alergol. 2017;34:70-6. https://doi.org/10.5114/pdia.2016.57679 PMid:28261034 DOI: https://doi.org/10.5114/pdia.2016.57679
Chen Q, Zhong H, Chen WC, Zhai Z, Zhou Z, Song Z, et al. Different expression patterns of plasma Th1-, Th2-, Th17- and Th22-related cytokines correlate with serum autoreactivity and allergen sensitivity in chronic spontaneous urti-caria. J Eur Acad Dermatol Venereol. 2018;32:441-8. https://doi.org/10.1111/jdv.14541 PMid:28846158 DOI: https://doi.org/10.1111/jdv.14541
Lee JK, Simpson RS. Dupilumab as a novel therapy for difficult to treat chronic spontaneous urticaria. J Allergy Clin Immunol Pract. 2019;7:1659-61. https://doi.org/10.1016/j.jaip.2018.11.018 PMid:30496828 DOI: https://doi.org/10.1016/j.jaip.2018.11.018
Yu Q, Lin W, Zhang J, Peng L, Kong Q, Zhong R, et al. The association of Th17/Treg cells ex-pression in peripheral blood and chronic spontaneous urticaria: A protocol of systematic review and meta-analysis. Medicine (Baltimore). 2020;99:e22014. https://doi.org/10.1097/MD.0000000000022014 PMid:32899053 DOI: https://doi.org/10.1097/MD.0000000000022014
Arshi S, Babaie D, Nabavi M, Tebianian M, Ghalehbaghi B, Jalali F, et al. Circulating level of CD4+ CD25+ FOXP3+ T cells in patients with chronic urticaria. Int J Dermatol. 2014;53:e561-6. https://doi.org/10.1111/ijd.12630 PMid:25311400 DOI: https://doi.org/10.1111/ijd.12630
Moos Ł, Kapeluszna K, Okuniewicz R, Brzoza Z. The role of interleukin 10 and 18 in chronic spontaneous urticaria pathogenesis in the context of angioedema coexistence. J. Interferon Cytokine Res. 2021;41:172-6. https://doi.org/10.1089/jir.2020.0256 PMid:34003678 DOI: https://doi.org/10.1089/jir.2020.0256
Feng H, Feng J, Zhang Z, Xu Q, Hu M, Wu Y, et al. Role of IL-9 and IL-10 in the pathogenesis of chronic spontaneous urticaria through the JAK/STAT signalling pathway. Cell Biochem Funct. 2020;38:480-9. https://doi.org/10.1002/cbf.3481 PMid:31989663 DOI: https://doi.org/10.1002/cbf.3481
Patel OP, Giorno RC, Dibbern DA, Andrews KY, Durairaj S, Dreskin SC. Gene expression profiles in chronic idio-pathic (spontaneous) urticaria. Allergy Rhinol. 2015;6:101-10. https://doi.org/10.2500/ar.2015.6.0124 PMid:26302730 DOI: https://doi.org/10.2500/ar.2015.6.0124
Santos JC, de Brito CA, Futata EA, Azor MH, Orii NM, Maruta CW, et al. Up-regulation of chemokine C-C ligand 2 (CCL2) and C-X-C chemokine 8 (CXCL8) expression by monocytes in chronic id-iopathic urticaria. Clin Exp Immunol. 2012;167:129-36. https://doi.org/10.1111/j.1365-2249.2011.04485.x PMid:22132892 DOI: https://doi.org/10.1111/j.1365-2249.2011.04485.x
Downloads
Published
How to Cite
License
Copyright (c) 2022 Alina Petruk, Iryna Kamyshna, Mariia Shkilna, Alexandr M. Kamyshnyi (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0